PPC
MRNA icon

Park Place Capital’s Moderna MRNA Stock Holding History

Park Place Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7
Closed -$696 – 913
2023
Q4 		$696 Sell
7
-74
-91% -$6.22K ﹤0.01% 842
2023
Q3 		$8.37K Buy
81
+2
+3% +$223 ﹤0.01% 789
2023
Q2 		$9.6K Buy
79
+3
+4% +$400 ﹤0.01% 772
2023
Q1 		$11.7K Buy
76
+53
+230% +$8.74K ﹤0.01% 742
2022
Q4 		$4K Buy
+23
New +$3.76K ﹤0.01% 888

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Park Place Capital's MRNA Position: Q1 2024 in Review

Park Place Capital sold out of Moderna (MRNA) in Q1 2024, closing a stake of 7 shares — an estimated $696 sold.

Park Place Capital first reported a position in MRNA in Q4 2022 and held it in 5 quarters. The position peaked at $11.7K in Q1 2023. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Park Place Capital reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Park Place Capital sold 7 Moderna shares in Q1 2024, an estimated $696.
  • Park Place Capital first reported a position in Moderna in Q4 2022 and held it in 5 quarters.
  • Park Place Capital's Moderna position peaked at $11.7K in Q1 2023.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Park Place Capital's 13F filing for Q1 2024, filed 18 Apr 2024.